End-Of-Life Research: Do We Need to Build Proxy Consent Into All Clinical Trial Protocols Studying the Terminal Phase?

Journal of Palliative Medicine - United States
doi 10.1089/jpm.2012.0161
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy